• 31 Aug 21

Futura Medical reaches licensing deal for erectile dysfunction gel in Brazil and Mexico

Futura Medical reaches licensing deal for erectile dysfunction gel in Brazil and Mexico

Futura Medical plc | FUM | 0.4 0 0%

    • 166 views

 

Futura Medical PLC (AIM:FUM) chief executive James Barder joined Proactive's Stephen Gunnion with news of a licensing deal which should see its fast-acting erectile dysfunction gel introduced to Brazil and Mexico.

Barder telling Proactive that it will receive payments on all sales of its MED3000 treatment by m8 Pharmaceuticals.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Futura Medical: new US Eroxon deal and positive WSD4000 women's health data

Companies: Futura Medical plc

Futura Medical head of R&D details progress on WSD4000 for women

Companies: Futura Medical plc

Futura Medical, Ilika, Rome Resources, Galantas Gold, Supermarket Income REIT - Small Cap Snapshot

Companies: Futura Medical plc

Futura Medical "on track for a profit in 2025" after strong first half

Companies: Futura Medical plc

Futura Medical, Rome Resources, IXICO, Future PLC, Mediazest - Small Cap Snapshot

Companies: Futura Medical plc

Futura Medical - Fireside Chat

Companies: Futura Medical plc

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top